Stereotactic Body Radiation Therapy With or Without Nivolumab in Treating Patients With Stage I-IIA or Recurrent Non-small Cell Lung Cancer

Clinical trial NCT03110978 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT03110978
Sponsor: M.D. Anderson Cancer Center
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Lung Atypical Carcinoid Tumor Lung Neuroendocrine Neoplasm Lung Non-Small Cell Squamous Carcinoma Minimally Invasive Lung Adenocarcinoma Neuroendocrine Carcinoma Recurrent Lung Adenocarcinoma Recurrent Lung Large Cell Carcinoma Recurrent Lung Non-Small Cell Carcinoma Stage I Lung Cancer AJCC v8 Stage IA1 Lung Cancer AJCC v8 Stage IA2 Lung Cancer AJCC v8 Stage IA3 Lung Cancer AJCC v8

Start date: 2017-06-26
Primary completion: 2028-06-30
Enrollment: 140

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.